Respiratory muscle training moderately improved lung function, especially respiratory muscle strength, in patients with amyotrophic lateral sclerosis (ALS) compared with no intervention or sham ...

US FDA grants orphan drug designation to Klotho Neurosciences’ KLTO-202 to treat amyotrophic lateral sclerosis: New York Saturday, July 12, 2025, 15:00 Hrs [IST] Klotho Neurosci ...

Documenting his experiences has proven to be the outlet Darin Nakakihara needs in the wake of his ALS diagnosis.

Explore Our Free-Market Analysis Sample – Instant Access: – https://www.astuteanalytica.com/request-sample/amyotrophic-lateral-sclerosis-treatment-market ...

A Japanese research team has discovered a cause of amyotrophic lateral sclerosis (ALS), a progressive, terminal ...

Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

Ms Siti Nur Sabrina Anis, 26, had to swop one set of wheels for another – her Yamaha motorcycle for a motorised wheelchair.

The amount of lives that he touched and changed for the better number in the thousands," his stepdaughter wrote.

Shanghai Zhimeng Biopharma, Inc. ("Zhimeng Biopharma"), a clinical-stage biopharmaceutical company dedicated to innovative drug development for liver and central nervous system (CNS) diseases, today ...

Recent brain-computer-interface (BCI) devices have made it possible to translate neural activity directly into text and even ...

Investing.com -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) stock surged 22% after the company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its ...